Literature DB >> 14638779

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.

Evans L N Taracha1, Richard Bishop, Antony J Musoke, Adrian V S Hill, Sarah C Gilbert.   

Abstract

Heterologous priming-boosting vaccination regimens involving priming with plasmid DNA antigen constructs and inoculating (boosting) with the same recombinant antigen expressed in replication-attenuated poxviruses have recently been demonstrated to induce immunity, based on CD4(+)- and CD8(+)-T-cell responses, against several diseases in both rodents and primates. We show that similar priming-boosting vaccination strategies using the 85A antigen of Mycobacterium tuberculosis are effective in inducing antigen-specific gamma interferon-secreting CD4(+) and CD8(+) T cells, detected by a bovine enzyme-linked immunospot assay, in Bos indicus cattle. T-cell responses induced by priming with either plasmid DNA or fowlpox virus 85A constructs were enhanced by boosting with modified vaccinia virus Ankara expressing the same antigen administered intradermally. On the basis of the data, it appears that intradermal priming was more effective than intramuscular delivery of the priming dose for boosting with the modified vaccinia virus Ankara strain in cattle. Using either fowlpox virus or DNA priming, there was a significant bias toward induction of CD4(+)- rather than CD8(+)-T-cell responses. These data illustrate the general applicability of priming-boosting vaccination strategies for induction of antigen-specific T-cell responses and suggest that the method may be useful for development of veterinary vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638779      PMCID: PMC308883          DOI: 10.1128/IAI.71.12.6906-6914.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen.

Authors:  O Bruña-Romero; G González-Aseguinolaza; J C Hafalla; M Tsuji; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 2.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  Rama Rao Amara; Francois Villinger; John D Altman; Shari L Lydy; Shawn P O'Neil; Silvija I Staprans; David C Montefiori; Yan Xu; James G Herndon; Linda S Wyatt; Maria Angelito Candido; Natalia L Kozyr; Patricia L Earl; James M Smith; Hak-Ling Ma; Bennett D Grimm; Michael L Hulsey; Harold M McClure; Janet M McNicholl; Bernard Moss; Harriet L Robinson
Journal:  Vaccine       Date:  2002-05-06       Impact factor: 3.641

3.  An experiment to challenge the resistance to tuberculosis in B.C.G. vaccinated cattle in Malawi.

Authors:  F G Waddington; D C Ellwood
Journal:  Br Vet J       Date:  1972-11

Review 4.  Vaccination of cattle against Mycobacterium bovis.

Authors:  B M Buddle
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

Review 5.  Mycobacterium bovis infection in human beings.

Authors:  J M Grange
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

6.  Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.

Authors:  A Tanghe; S D'Souza; V Rosseels; O Denis; T H Ottenhoff; W Dalemans; C Wheeler; K Huygen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.

Authors:  Lise Brandt; Joana Feino Cunha; Anja Weinreich Olsen; Ben Chilima; Penny Hirsch; Rui Appelberg; Peter Andersen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 9.  The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.

Authors:  H G Wiker; M Harboe
Journal:  Microbiol Rev       Date:  1992-12

10.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

Authors:  S Chakrabarti; K Brechling; B Moss
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

View more
  6 in total

1.  Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.

Authors:  H Martin Vordermeier; Shelley G Rhodes; Gillian Dean; Nilu Goonetilleke; Kris Huygen; Adrian V S Hill; R Glyn Hewinson; Sarah C Gilbert
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

2.  Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes.

Authors:  Simon P Graham; Roger Pellé; Yoshikazu Honda; Duncan M Mwangi; Nyerhovwo J Tonukari; Mat Yamage; E Jane Glew; Etienne P de Villiers; Trushar Shah; Richard Bishop; Evelyne Abuya; Elias Awino; James Gachanja; Anthony E Luyai; Ferdinand Mbwika; Anthony M Muthiani; David M Ndegwa; Moses Njahira; John K Nyanjui; Fredrick O Onono; Julius Osaso; Rosemary M Saya; Claude Wildmann; Claire M Fraser; Ian Maudlin; Malcolm J Gardner; Subhash P Morzaria; Sheena Loosmore; Sarah C Gilbert; Jean-Christophe Audonnet; Pierre van der Bruggen; Vishvanath Nene; Evans L N Taracha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

3.  Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.

Authors:  Alexandra J Spencer; Fergal Hill; Jared D Honeycutt; Matthew G Cottingham; Migena Bregu; Christine S Rollier; Julie Furze; Simon J Draper; Karen C Søgaard; Sarah C Gilbert; David H Wyllie; Adrian V S Hill
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

4.  A novel strategy for the identification of antigens that are recognised by bovine MHC class I restricted cytotoxic T cells in a protozoan infection using reverse vaccinology.

Authors:  Simon P Graham; Yoshikazu Honda; Roger Pellé; Duncan M Mwangi; E Jane Glew; Etienne P de Villiers; Trushar Shah; Richard Bishop; Pierre van der Bruggen; Vishvanath Nene; Evans L N Taracha
Journal:  Immunome Res       Date:  2007-02-09

5.  DNA vaccines: designing strategies against parasitic infections.

Authors:  Catherine Ivory; Kris Chadee
Journal:  Genet Vaccines Ther       Date:  2004-12-03

6.  Swinepox virus vector-based vaccines: attenuation and biosafety assessments following subcutaneous prick inoculation.

Authors:  Xiaomin Yuan; Huixing Lin; Bin Li; Kongwang He; Hongjie Fan
Journal:  Vet Res       Date:  2018-02-07       Impact factor: 3.683

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.